Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1224-1232

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Räihä, I.
Right arrow Articles by Sourander, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Räihä, I.
Right arrow Articles by Sourander, L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Vascular Diseases
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1224-1232.)
© 1997 American Heart Association, Inc.


Articles

Effect of Serum Lipids, Lipoproteins, and Apolipoproteins on Vascular and Nonvascular Mortality in the Elderly

I. Räihä; J. Marniemi; P. Puukka; T. Toikka; C. Ehnholm; ; L. Sourander

From the Department of Geriatrics, University of Turku, Turku, Finland (I.R., L.S.); the Research and Development Centre of the Social Insurance Institution, Turku, Finland (J.M., P.P., T.T.); and the Department of Biochemistry, National Public Health Institute, Helsinki, Finland (C.E.).

Correspondence to I. Räihä, Department of Geriatrics, University of Turku, Kunnallissairaalantie 20, FIN-20700 Turku, Finland.

Abstract The purpose of this study was to determine the effect of serum lipids, lipoprotein fractions, and apolipoprotein (apo) A-1, B, and E on mortality from vascular and nonvascular causes in an unselected elderly population. The random sample of 347 community-living individuals aged 65 years or older was obtained in 1982. Serum total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), triglyceride, and apo A-1, B, and E were determined at baseline. After the 11-year follow-up, 199 of the participants had died, and 148 were still alive. Mortality data from vascular and nonvascular causes by the end of 1993 were obtained from official registers. In the univariate analysis, a low total cholesterol level was associated with death due to both vascular and nonvascular causes (P value for trend, .021 and .0027, respectively). After the adjustment for other risk factors, the inverse association between total cholesterol and vascular mortality disappeared, but low total cholesterol was still a significant predictor of death due to nonvascular causes. Adjusted relative risks (RRs) of death due to nonvascular causes for those with elevated total cholesterol (5.1 to 6.5, 6.6 to 8.0, and >8.0 mmol/L) compared with the reference group (<=5.0 mmol/L) were 0.5 (95% confidence interval [CI], 0.2 to 1.2), 0.6 (0.2 to 1.0), and 0.2 (0 to 0.8), respectively. Neither concentrations of HDL-C, LDL-C, triglyceride, nor apo B were associated with vascular or nonvascular mortality. On the other hand, low concentration of apo A-1 predicted vascular death. The RR for the lowest tertile was 1.6 (1.1 to 2.5) compared with the highest tertile. Furthermore, the occurrence of the apo E e4 allele was associated with increased risk of vascular mortality (RR, 1.5; 95% CI, 1.0 to 2.2), but the risk was not related to the levels of lipids, lipoproteins, or other apolipoproteins at baseline. Nonvascular mortality also tended to be predicted by the presence of the e4 allele (RR, 1.5; 95% CI, 0.9 to 2.5). In an unselected elderly population, the allelic variation of apo E, ie, the presence of the e4 allele, and a low concentration of apo A-1 were more accurate indicators of vascular mortality than total cholesterol or lipoprotein fractions. The risk associated with the apo E polymorphism is unrelated to dyslipidemia.


Key Words: apolipoprotein A-1 • apolipoprotein E • cholesterol • coronary heart disease • elderly • mortality • prognosis




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. C. Ewbank
Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2007; 62(8): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. E. Strandberg, A. Strandberg, K. Rantanen, V. V. Salomaa, K. Pitkala, and T. A. Miettinen
Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up
J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1002 - 1008.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
U. Ravnskov
High cholesterol may protect against infections and atherosclerosis
QJM, December 1, 2003; 96(12): 927 - 934.
[Full Text] [PDF]


Home page
CirculationHome page
H. V. Huikuri, T. H. Makikallio, K. E. J. Airaksinen, T. Seppanen, P. Puukka, I. J. Raiha, and L. B. Sourander
Power-Law Relationship of Heart Rate Variability as a Predictor of Mortality in the Elderly
Circulation, May 26, 1998; 97(20): 2031 - 2036.
[Abstract] [Full Text] [PDF]